Melior Resources: Restarting Ilmenite Production at Gunda Camile with Strong Financing and Market Potential 00:10:00
Andrew Reaume is Pres/CEO/Co-Founder at Melior Discovery Inc. Developer of in vivo pharmacology intended to identify indications for pre-clinical and development-stage drug candidates. The company specializes in offering rapid and cost-effective identification of new therapeutic potential by systematically screening candidates in a diverse array of validated in vivo disease models, enabling clients to get bioanalytical testing products.
